SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-135394
Filing Date
2021-11-08
Accepted
2021-11-08 08:46:08
Documents
47
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q clrb-20210930x10q.htm   iXBRL 10-Q 1111070
2 EXHIBIT 31.1 clrb-20210930xex31d1.htm EX-31.1 13891
3 EXHIBIT 31.2 clrb-20210930xex31d2.htm EX-31.2 13925
4 EXHIBIT 32.1 clrb-20210930xex32d1.htm EX-32.1 8898
  Complete submission text file 0001104659-21-135394.txt   4401520

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA clrb-20210930.xsd EX-101.SCH 30666
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clrb-20210930_cal.xml EX-101.CAL 28226
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clrb-20210930_def.xml EX-101.DEF 159975
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE clrb-20210930_lab.xml EX-101.LAB 259454
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clrb-20210930_pre.xml EX-101.PRE 228597
10 EXTRACTED XBRL INSTANCE DOCUMENT clrb-20210930x10q_htm.xml XML 678769
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36598 | Film No.: 211386666
SIC: 2834 Pharmaceutical Preparations